Erin Creber
Automatically compiled listing. Details may contain errors.Partner at Gowling WLG
- Called to the bar
- 2012
- Languages
- English
Intellectual PropertyPartner at Gowling WLG
Intellectual PropertyErin Creber is an Ottawa partner at Gowling WLG whose courtroom work centres on intellectual property. Clients come from life sciences, technology and manufacturing, and pharmaceutical companies are among those who turn to Erin for advice.
Science came before law. Erin holds a chemical engineering degree and an economics degree from Queen's, then earned a JD at Western in 2011 and was called to the Ontario bar the following year. Trademark agent registration came in 2013. In 2019 Erin passed CIPO's patent agent qualifying exam and joined Gowling's Ottawa patent agents, taking on prosecution and IP litigation in bioengineering, biomaterials, chemical processing and manufacturing, and chemical engineering.
Being both a lawyer and a registered agent means Erin can stay with a client from protecting an invention or brand through to enforcing it in court. Erin has appeared as counsel at the Federal Court, the Federal Court of Appeal and the Supreme Court of Canada, handling trials as well as appeals, and has led patent enforcement that spanned more than one jurisdiction. Not every dispute ends in a judgment, either: Erin regularly helps clients negotiate settlements and strategic business deals, with the focus kept on advice that's practical and makes commercial sense.
Erin litigates drug patent disputes under the PMNOC Regulations, at trial and on appeal, and has acted as counsel of record in proceedings involving Astellas and Sandoz over MYRBETRIQ, Novartis and Pharmascience over ENTRESTO, and Bayer and Amgen Canada over EYLEA.
Erin's IP litigation isn't limited to patents. It also takes in trademarks, industrial designs and copyright, along with related regulatory issues.
Erin has been counsel of record in proceedings brought against the Commissioner of Patents by CAE, Genentech and Novartis AG.
Erin was one of the Gowling WLG lawyers representing interveners David Homuth, Marco Solmi and Pierre Bleau in this appeal over whether a patent was invalid for claiming an unpatentable method of medical treatment. The Court dismissed the appeal from 2024 FCA 23 without costs on July 17, 2026.
Decisions where Erin Creber appeared as counsel, from public court records. Past cases don't predict future results.
Something wrong with this listing? Tell us and we’ll hide it right away while we review your request, then correct it or take it down.
Add the free LawOnline listing badge to your website. It tells visitors you’re listed in an independent Canadian lawyer directory and links back to this profile. Being listed isn’t a certification or an endorsement, and the badge doesn’t mean we’ve checked your credentials.
This listing was generated by AI from public sources in October 2026. It may contain errors, and we can’t guarantee it’s accurate or complete. Before you rely on anything here, verify it on their firm’s website. Confirm Erin Creber’s licence and standing in the Law Society of Ontario directory ↗
How this data is compiled and checked · Correct or remove this listing